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ABSTRACT. In this study, the occurrence of the ciprofloxacin-resistant (CR) Escherichia coli in chicken meat was 
determined, and their clonal relations were investigated by using pulsed-field gel electrophoresis (PFGE). Antimi-
crobial resistance patterns of E. coli isolates were determined by using disc diffusion assay, and minimum inhibitory 
concentration of ciprofloxacin was determined by E-test. Plasmid-mediated quinolone resistance (PMQR) and extend-
ed spectrum beta-lactamase (ESBL) resistance genes were also screened through polymerase chain reactions. Sixty 
chicken meat samples were collected from different supermarkets and butchers in Sivas, Turkey. CR E. coli strains 
were determined in 59 (98.3%) chicken meat samples. By analyzing PFGE fingerprint data, 34 different pulsotypes 
were determined. All E. coli strains were found to be resistant to nalidixic acid, enrofloxacin, and norfloxacin. In addi-
tion, isolates were resistant to levofloxacin (40.7%), ampicillin (94.9%), trimethoprim-sulfamethoxazole (76.3%), tet-
racycline (69.5%), and chloramphenicol (44.1%). However, isolates were susceptible to imipenem and colistin. In this 
study, 81.4% of CR E. coli isolates were observed to have a multidrug-resistant profile, which is defined as resistance 
to three or more classes of antibiotics. Through phenotypic confirmation tests, five isolates (8.3%) were determined 
to be ESBL-producing. The PMQR genes were not determined in any of the isolates. Two isolates (3.4%) possessed 
the blaCTX-M and blaCMY-2 genes, and 40 isolates (67.8%) had the blaTEM gene. Taken together, retail raw chicken meat is 
highly contaminated with CR E. coli. However, these isolates are not found to be carriers of the PMQR genes, indicat-
ing a low public health problem. 
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Escherichia coli are commonly found in the gastro-intestinal tract of humans and warm-blooded ani-
mals and can cause enteritis, urinary tract infection, 
septicemia, pneumonia, and meningitis in humans 
and animals (Allocati et al., 2013; Ray, 2004). The 
emergence of antimicrobial resistance threatens the 
treatment of E. coli infections. The higher prevalence 
of multidrug-resistant (MDR) E. coli strains have in-
creased worldwide in the past few decades (Allocati 
et al., 2013; EFSA, 2019; Mavroidi et al., 2012). It is 
a well-known fact that the primary reason for the high 
prevalence of MDR E. coli is the unregulated use of 
antimicrobial agents in humans and animals (Seo and 
Lee, 2019). 
Quinolones are broad-spectrum antibiotics wide-
ly used against gram-negative bacteria, including E. 
coli infections in human and veterinary medicines, 
which has eventually resulted in the rapid emergence 
of quinolone resistant bacteria (Borjesson et al., 2016; 
EFSA, 2019; WHO, 2007). The first generation of 
quinolone molecules were licensed for use in food an-
imals at the beginning of the 1980s, and fluoroquino-
lones were licensed during the late 1980s and early 
1990s (EMEA, 2006). Since then, new fluoroquino-
lone molecules have been authorized, and a number 
of different veterinary medicines are now available on 
the market (EMEA, 2006; Gouvea et al., 2015). 
Two main mechanisms of quinolone resistance 
have been described: (i) alterations in the targets of 
quinolones, and (ii) decreased accumulation inside 
the bacteria due to decreased permeability of the 
membrane and/or an overexpression of efflux pump 
systems. Both of these mechanisms are noted to be 
chromosomally mediated (Ruiz, 2003). Chromosom-
al mutations located in the quinolone resistance-deter-
mining regions (QRDRs) of the gyrA and gyrB genes, 
which encode for the two DNA gyrase (topoisomer-
ase II) subunits, and the ParC and ParE genes, which 
encode for two topoisomerase IV subunits (Jacoby, 
2005). In addition, plasmid-mediated quinolone resis-
tance (PMQR) genes were also noted to contribute to 
quinolone resistance by either altering the molecular 
structure of quinolone target enzymes or the enzymat-
ic inhibition of quinolones (Martinez-Martinez et al., 
1998). 
PMQR genes, first reported in a pMG252 plasmid 
from a Klebsiella pneumoniae strain, were obtained 
from a patient’s urine specimen at the University of 
Alabama, Birmingham in 1994 (Martinez-Martinez 
et al., 1998). To date, different PMQR determinants 
have been identified, the qnr families, aac(6’)-Ib-cr 
(drug modification), and  qepA and oqxAB (active ef-
flux pumps) (Rodriguez-Martinez et al., 2016), and 
are usually associated with mobile elements on plas-
mids often found to be incorporated into sul1-type in-
tegrons. Their sequences have been uploaded into the 
following web-based database: http://www.lahey.org/
qnrStudies/ (Jacoby et al., 2014; Martinez-Martinez 
et al., 2008). Importantly, mobile genetic elements 
carrying PMQR genes commonly carry other import-
ant antimicrobial resistance traits, such as extended 
spectrum β-lactamase (ESBL) genes (Robicsek et al., 
2006; Allocati et al., 2013). 
Despite the fact that the quinolones have never 
been used in Norway livestock production, cipro-
floxacin resistance was determined by using selective 
method. These particular situations paved the way for 
investigations of PMQR genes in food from animal 
origins, especially in chicken meat, and were found 
to be significant from a public health point of view 
(Slettemeas et al., 2019). Although ciprofloxacin has 
been widely used in human and veterinary medicines 
in Turkey (Nazik et al., 2008; Şahintürk et al., 2016). 
Thus, the main aim of this study was to determine the 
occurrence of ciprofloxacin resistant E. coli strains 
by using selective enrichment and molecular char-
acterization of PMQR (qnrA, qnrB, qnrS, qnrC and 
aac(6’-lb-cr) in these isolates. The isolates were fur-
ther characterized by pulsed-field gel electrophoresis 
(PFGE), and the presence of genes encoding differ-
ent β-lactamases (blaCTX-M, blaCMY-2, blaTEM and blaSHV) 
was investigated. 
MATERIALS AND METHODS
Sample Collection and Isolation of Ciprofloxacin 
Resistant E. coli 
Sixty chicken meat samples were collected from 
different supermarkets and butchers from September 
to December 2018 in Sivas, Turkey. For the E. coli 
isolation, each chicken meat sample (25 g) was sus-
pended in 225 mL of sterile Buffered peptone water 
(Oxoid CM0509) and was mixed by paddle blender 
(Interscience Bag Mixer, France) for 2 min. Then, 
the homogenate was incubated for 24 h at 37°C. At 
the end of the incubation, 100 µL of the enrichment 
was plated on a Tryptone bile x-glucuronide (TBX) 
agar plate (Oxoid, CM0945), including 0.5 µg/mL 
ciprofloxacin (Sigma-Aldrich, U.S.A), and incubated 
for 3 h at 44°C and then 24 h at 41°C. After incuba-
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tion, green E. coli colonies (one colony per sample) 
isolated from each sample were subcultured on Co-
lumbia blood agar (Oxoid, CM0331). Isolates were 
stored in Tryptone soya broth (Oxoid CM0129) with 
20% glycerol at -20°C. Species identification was 
performed using a MALDI-TOF (Bruker Daltonik 
GmbH, Leipzig, Germany). To identify bacterial spe-
cies, each peak was directly matched against refer-
ence libraries and a result was considered valid (ac-
curate identification to the species level) if the score 
value was ≥ 2.0. When the scores obtained were < 2.0, 
the samples were reevaluated. 
Pulsed-Field Gel Electrophoresis 
The genetic relatedness of the E. coli isolates in the 
current study was assessed by a PFGE procedure, and 
band profile analyses were performed by the Public 
Health Institution of Turkey (Ankara), as described 
previously (Durmaz et al., 2009), with XbaI restric-
tion of DNA. The DNA band profiles were analyzed 
by using the BioNumerics software system (Applied 
Maths, Sinth-Martens-Latem, Belgium). A 1% band 
tolerance was used for the comparison of DNA pro-
files. Cluster analysis was done by the unweighted 
pair group method using with arithmetic mean (UP-
GMA). The level of the Dice similarity between pat-
terns was defined at ≥ 85%. 
Antimicrobial Susceptibility Testing 
The antimicrobial susceptibilities of all the CR 
E. coli isolates were determined by the disc diffu-
sion method in accordance with the CLSI guidelines 
(CLSI, 2015). The following discs of antibiotics 
(Bioanalyse, Turkey) were used: amoxicillin-clavu-
lanic acid (AMC; 20/10 μg), ampicillin (AM; 10 μg), 
aztreonam (ATM; 30 μg), cefoxitin (FOX; 30 μg), 
cefuroxime (CXM; 30 μg), cefpodoxime (CPD; 30 
μg), colistin (CT; 10 μg), imipenem (IPM; 10 μg), 
chloramphenicol (C; 30 μg), gentamicin (CN; 10 μg), 
tetracycline (TE; 30 μg), nalidixic acid (NA; 30 μg), 
ciprofloxacin (CIP; 5 μg), enrofloxacin (ENR; 30 μg), 
levofloxacin (LEV; 5 μg), norfloxacin (NOR; 30 μg), 
trimethoprim-sulfamethoxazole (SXT; 1.25/23.75 
μg), and bacitracin (B; 30 μg). E. coli (ATCC 25922) 
was used as the standard strain in the disc diffusion 
assay, and the results were interpreted according to 
CLSI guidelines (CLSI, 2015). In addition, E-tests 
(Bioanalyse, Ankara, Turkey) determined the mini-
mum inhibitory concentrations (MICs) of ciprofloxa-
cin. Briefly, broth suspensions of E. coli strains equiv-
alent to a 0.5 McFarland standard were prepared and 
inoculated on Mueller-Hinton agar (Oxoid CM0337) 
plate. E-test strips were placed on the dry medium, 
which was then incubated under aerobic conditions 
for 24 h at 37°C. The cutoff breakpoints for cipro-
floxacin were set at ≥ 4 µg/mL in accordance with the 
CLSI’s epidemiological cutoff values (CLSI, 2015).
Determination and Characterization of PMQR 
and β-Lactamase Genes
All primers in this study are listed in Table 1. The 
genomic DNA was extracted by a standard boiling 
method, and the presence of the PMQR genes (qnrA, 
qnrB, qnrS, qnrC, qnrD and aac(6’)-Ib-cr) were de-
termined by PCR (Park et al., 2006; Robicsek et al., 
2006). PCR reactions were prepared as 50 μL [5 µL 
10x PCR buffer, 5 μL 25 mM MgCl2, 250 μM from 
each dNTP, 1.25 U Taq DNA Polymerase (MBI, 
Fermentas), 50 ρmol for each primer, and 25 ƞg ge-
nomic DNA]. The PCR protocol was conducted by 
using a Bio-Rad T100 gradient thermal cycler device 
(BioRad, California, USA). The PCR conditions were 
carried out in the following steps: initial denaturation 
at 94°C for 45 s (denaturation at 53°C for 45 s and 
hybridization at 72°C for 60 s) for 32 cycles. Screen-
ing for aac(6’)-Ib-cr was carried out by PCR ampli-
fication, as previously described by Park et al. (2006) 
PCR conditions were carried out through the follow-
ing steps: initial denaturation at 94°C for 45 s (dena-
turation at 55°C for 45 s and hybridization at 72°C for 
45 s) for 34 cycles. PCR products were run on electro-
phoresis in 1.5% (w/v) agarose gel and stained with 
ethidium bromide (10 mg/mL) for 30 min, and then 
screened under an ultraviolet transilluminator (Vilber 
Lourmat Quantum ST4, Marne-la-Vallee Cedex 1, 
France), using a 100 bp DNA ladder (MBI, Fermen-
tas) as reference. To detect CTX-M, CMY-2, TEM, 
and SHV type β-lactamase, the blaCTX-M,  blaCMY-2, 
blaTEM, and blaSHV genes were also amplified by PCR 
assay, which was conducted as described (Hasman et 
al., 2005; Leinberger et al., 2010; Mulvey et al., 2003). 
The β-lactamase genes were confirmed by sequencing 
the PCR products, as described previously (Ahmed 
et al., 2007). PCR-positive amplicons were obtained 
from National Food Institute EURL-AR reference 
strains collection, Technical University of Denmark 
were used, and distilled water was used for the neg-
ative control. (https://www.eurl-ar.eu/resources.aspx-
#refstrains)
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Table 1. Primer sequence of the used in PCR
Genes Primer sequence (5´-3´) Product size (bp) References
qnrA F:GGATGCCAGTTTCGAGGAR:TGCCAGGCACAGATCTTG 492 Cavaco et al., 2008
qnrB F:GGMATHGAAATTCGCCACTGR:TTTGCYGYYCGCCAGTCGAA 262 Cattoir et al., 2007
qnrS F:TCGACGTGCTAACTTGCGR:GATCTAAACCGTCGAGTTCGG 466 Cavaco et al., 2008
qnrC F:GGGTTGTACATTTATTGAATCGR:CACCTACCCATTTATTTTCA 307 Jacoby et al., 2009
qnrD F:CGAGATCAATTTACGGGGAATAR:AACAAGCTGAAGCGCCTG 582 Cavaco et al., 2009
aac(6’)-Ib-cr F:TTGCGATGCTCTATGAGTGGCTAR:CTCGAATGCCTGGCGTGTTT 482 Park et al., 2006
blaCTX-M
F:ATGTGCAGYACCAGTAARGTKATGGC
R:TGGGTRAARTARGTSACCAGAAYCAGCGG 593 Mulvey et al., 2003
blaCMY-2
F:GCACTTAGCCACCTATACGGCAG
R:GCTTTTCAAGAATGCGCCAGG 758 Hasman et al., 2005
blaTEM
F:TGAGTATTCAACATTTCCGTGT
R:TTACCAATGCTTAATCAGTGA 861 Leinberger et al., 2010
blaSHV
F:CAAAACGCCGGGTTATTC
R:TTAGCGTTGCCAGTGCT 937 Leinberger et al., 2010
RESULTS
In this study, 59 (98.3%) CR E. coli isolates were 
obtained from 60 chicken meat samples. Of these 59 
isolates, 34 different pulsotypes were obtained when 
the similarity threshold was taken as ≥ 85%. Among 
these pulsotypes, 18 isolates were determined as clon-
ally unrelated, and the remaining 41 were found to be 
related, which resulted in 16 groups with two to four 
isolates in each group (Fig 1). 
The results of the antimicrobial susceptibility tests 
of the CR E. coli strains from chicken meat samples 
are shown in Table 2. Fifty-nine CR E. coli isolates 
and the susceptibility to 12 antimicrobial classes 
of these isolates were obtained from chicken meat 
samples. According to the results, all E. coli strains 
(100%) were determined as resistant to B, NA, ENR, 
and NOR. However, 40.7% of the strains were deter-
mined resistant to LEV, and 94.9%, 76.3%, 69.5%, 
and 44.1% of the E. coli strains were determined re-
sistant to AM, SXT, TE, and C, respectively. On the 
other hand, all E. coli strains were susceptible to IPM 
and CT. Additionally, susceptibility to FOX and ATM 
were 93.2% and 96.6% among all E. coli strains, re-
spectively. MDR (≥ 3 different antimicrobial classes) 
was observed in 48 (81.4%) of the 59 isolates (Ta-
ble 3). MDR profiles were assessed as the following: 
seven (14.6%) isolates were resistant to three antimi-
crobial classes, 11 (22.9%) isolates were resistant to 
four, 15 (31.3%) isolates were resistant to five, nine 
(18.7%) isolates were resistant to six, five (10.4%) iso-
lates were resistant to seven, and one (2.1%) isolate 
was resistant to eight antimicrobial classes. MIC val-
ues of CIP-resistant E. coli strains were determined as 
follows: ≥ 32 µg/mL (42 isolates), ≥ 16 µg/mL (three 
isolates), ≥ 12 µg/mL (two isolates), ≥ 8 µg/mL (sev-
en isolates), and ≥ 6 µg/mL (three isolates; Fig 1).
None of the PMQR genes (qnrA, qnrB, qnrS, qnrC, 
qnrD, and aac(6’)-Ib-cr) were present among the iso-
lates. Forty-six of the 59 CR E. coli isolates carried 
β-lactamase genes. Table 4 summarizes the results of 
the β-lactamase genes detected in CR E. coli isolates 
in this study. The blaTEM gene was observed as 
predominant in CR E. coli isolates, and β-lactamase 
gene characterization revealed that 67.8% of the iso-
lates had the blaTEM gene (n = 40), 3.4% of the isolates 
had the blaCTX-M and blaCMY-2 genes (n = 2), 3.4% of 
the isolates had the blaTEM and blaCTX-M genes (n = 2), 
and 3.4% of the isolates had the blaTEM and blaCMY-2 
genes (n = 2). None of the E. coli isolates contained 
the blaSHV gene (Table 4). All the ampicillin-resistant 
isolates possessed the blaTEM gene. 
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Table 2.  Antimicrobial resistance of ciprofloxacin-resistant Escherichia coli isolated from chicken meat by disc diffusion 
assay (n = 59)
Antimicrobial Class Antimicrobials
Number of isolates (%)
Resistant Intermediate Susceptible
Quinolones Nalidixic acid 59 (100) 0 0
Ciprofloxacin 56 (94.9) 3 (5.1) 0
Enrofloxacin 59 (100) 0 0
Levofloxacin 24 (40.7) 17 (28.8) 18 (30.5)
Norfloxacin 59 (100) 0 0
Polipeptid Bacitracin 59 (100) 0 0
Tetracyclines Tetracycline 41 (69.5) 2 (3.4) 16 (27.1)
Folate pathway inhibitors Trimethoprim-sulfamethoxazole 45 (76.3) 1 (1.7) 13 (22)
Aminoglycosides Gentamicin 15 (25.4) 0 44 (74.6)
Phenicols Chloramphenicol 26 (44.1) 4 (6.8) 29 (49.2)
β-lactam/β-lactamase inhibitör 
combinations
Amoxicillin-clavulanic acid 5 (8.5) 5 (8.5) 49 (83.1)
Penicillins Ampicillin 56 (94.9) 0 3 (5.1)
Cephems Cefoxitin 1 (1.7) 3 (5.1) 55 (93.2)
Cefpodoxime 9 (15.3) 0 50 (84.7)
Cefuroxime 5 (8.5) 5 (8.5) 49 (83.1)
Monobactams Aztreonam 1 (1.7) 1 (1.7) 57 (96.6)
Penems Imipenem 0 0 59 (100)
Lipopeptides Colistin 0 0 59 (100)
Table 3. Antimicrobial resistance class pattern distribution for 48 multidrug-resistant Escherichia coli isolates from chicken meat
Antimicrobial resistance class patterns No. of classes Frequency
No. of multidrug-resistant 
E. coli (%)
PCNs, PPs, FPIs 3 3 6.3
PCNs, PPs, TETs 1 2.1
PPs, FPIs, TETs 1 2.1
PCNs, PPs, TETs 1 2.1
PCNs, PPs, AMGs 1 2.1
PCNs, PPs, AMGs, FPIs 4 1 2.1
PCNs, PPs, FPIs, TETs 9 18.6
PCNs, PPs, PHs, FPIs  1 2.1
PCNS, PPs, AMGs, FPIs, TETs 5 2 4.2
PCNS, PPs, PHs, FPIs, TETs 11 22.9
PCNS, PPs, PHs, AMGs, FPIs 1 2.1
BL/BLICs, PCNs, CEPs, PPs, FPIs 1 2.1
PCNs, CEPs, PPs, PHs, FPIS, TETS 6 1 2.1
PCNs, CEPs, PPs, PHs, AMGs, FPIS 1 2.1
PCNs, PPs, PHs, AMGs, FPIS, TETS 7 14.5
PCNs, CEPs, PPs, PHs, AMGs, FPIs, TETs 7 1 2.1
PCNs, CEPs, PPs, MONs, AMGs, FPIs, TETs 1 2.1
BL/BLICs, PCNs, PPs, CEPs, AMGs, FPIs, TETs 1 2.1
BL/BLICs, PCNs, CEPs, PPs, PHs, FPIs, TETs 2 4.1
BL/BLICs, PCNs, PPs, CEPs, PHs, AMGs, FPIs, TETs 8 1 2.1
Total 48 (100)
AMGs, aminoglycosides; BL/BLICs, β-lactam/β-lactamase inhibitor combinations; CEPs, cephems; FPIs, folate pathway inhibitors; 
FPIS; PCNs, penicillins; MONs, monobactams; PHs, phenicols; TETs, tetracyclines; PPs, Polipeptids. 
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*AMC, amoxicillin-clavulanic acid; AM, ampicillin; ATM, aztreonam; FOX, cefoxitin; CXM, cefuroxime; CPD, cefpodoxime; C, 
chloramphenicol; CN, gentamicin; TE, tetracycline; NA, nalidixic acid; CIP, ciprofloxacin; ENR, enrofloxacin; LEV, levofloxacin; 
NOR, norfloxacin; SXT, trimethroprim-sulfamethoxazole; B, bacitracin. All E. coli strains were susceptible to imipenem and colistin, 
these two antimicrobials were net shown in the resistant profiles. - Not detected. 
Figure 1. PFGE analysis of ciprofloxacin-resistant Escherichia coli isolates. 
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Table 4. Molecular characterization of bla and PMQR genes among ciprofloxacin-resistant Escherichia coli isolates (n = 59)
bla gene and PMQR No. of isolates n (%)
TEM 40 (67.8) 
TEM and CTX-M 2 (3.4)
TEM and CMY-2 2 (3.4) 
CTX-M and CMY-2 2 (3.4) 
SHV -
qnr A, B ,S, C and aac (6’-lb-cr) -
- Not detected
DISCUSSION 
The use of antimicrobials as growth promotion 
agents in food-producing animals has been prohibited 
in Turkey since 2006 (RG, 2006). Recently, Turkish 
Poultry Meat Producers and Breeders Association 
data also highlighted the decreasing trend in the use 
of antimicrobial drugs in poultry production in Tur-
key (Elmas et al., 2019). However, the occurrence of 
CR E. coli was determined as 98.3% in the current 
study, clearly showing a high level of contamination 
for chicken meat on the retail market in Turkey. The 
results obtained in the present study are not surprising 
because Ghodousi et al. (2015) reported 88.8% of CR 
E. coli isolates from chicken meat in Italy. For ex-
ample, even though quinolone-based antibiotics have 
been not in use for poultry production, an increase in 
quinolone-resistant E. coli rates in broiler production 
processes were reported in Sweden (Borjesson et al., 
2016). However, the results of this study were found 
to be much higher than the results from other coun-
tries, for example 37.4% in China (Xu et al., 2014) 
and 26% in the Czech Republic (Literak et al., 2013). 
According to the PFGE analysis, CR E. coli iso-
lates from chicken meat were clonally different. Such 
a difference can be attributed to the movements of 
humans, chickens, and vectors, and indicates that 
the contamination might not originate from a sin-
gle source (Jakobsen et al., 2010; Sola-Gines et al., 
2015). For example, in a study of E. coli isolated 
from slaughter animals in Poland, Wasyl et al. (2014) 
identified quinolone resistance mechanisms and not-
ed chromosome-encoded quinolone resistance did not 
result from the spread of a single resistant clone, rath-
er this was due to antimicrobial pressure leading to 
the selection of random gyr and par mutants.
In the present study, CR E. coli isolates from 
chicken meat samples were extremely resistant to 
AM (100%), SXT (76.3%), and TE (69.5%). For in-
stance, in a previous study conducted by Ghoudousi 
et al. (2015) in Italy, 134 E. coli were isolated from 
109 chicken meat samples, and their resistance pat-
terns were found for CIP (88.8%), CN (14.1%), SXT 
(79.1%), and TE (91.8%). In a study conducted by 
Soufi et al. (2011), 166 E. coli isolates were obtained 
from poultry meat (whole carcasses of chickens and 
turkeys) in Tunisia, and a significantly high percent-
age of resistance to ampicillin, nalidixic acid, sul-
fonamides, and tetracycline (66-95%) were observed 
among the isolates from poultry meat. Moreover, in 
another study performed by Xu et al. (2014) in China, 
all of the E. coli isolates were also resistant to AM 
(100%), SXT (94.3%), and TE (94.3%). High rates 
of resistance were observed for tetracycline (69.5%) 
in this study and were similar to the results reported 
from other countries (Soufi et al., 2011; Ghodousi et 
al., 2015; Xu et al. 2014). This finding is not surpris-
ing, as quinolone-resistant E. coli isolates were found 
from broilers in Sweden, which never approved these 
antimicrobials in the poultry industry. 
In the current study, the CR E. coli isolates were 
mostly resistant to quinolone antibiotics, except for 
LEV. This resistance could be related to the levoflox-
acin molecule’s C-8 methodxy group and the fluori-
nated quinoloic acid cores, which is different than the 
ciprofloxacin (Fu et al., 2013; Lu et al., 2001). 
In this study, data showed that all 59 CR E. coli 
isolates had high levels of phenotypical MDR pro-
files (81.4%; n = 48) for the chicken meat in Turkey, 
which were resistant to three to eight classes of anti-
microbial agents. Similar studies from the Czech Re-
public, Italy, and China found MDR E. coli in retail 
chicken meat at 82%, 66.9% and 59.4%, respectively 
(Ghodousi et al., 2015; Literak et al., 2013; Xu et al., 
2014). In a study performed by Seo and Lee (2019) in 
Korea with 248 chicken meat samples, 152 isolates 
were observed to be positive for E.coli; 75 were iden-
tified as MDR E. coli. Of the MDR E. coli isolates, 
13.3% were observed to be positive for PMQR genes, 
and 41.3% of the MDR E. coli isolates were found to 
be carrying class 1 integrons. The authors suggested 
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that PMQR genes and class 1 integrons were widely 
distributed in E. coli isolates from chicken meat and 
were contributed to resistance to diverse antimicrobi-
al agents. In contrast, no PMQR genes (qnrA, qnrB, 
qnrS, qnrC, qnrD, and aac(6’)-Ib-cr) were detected 
in this study. The PMQR genes were rare for Turkey 
(Kürekci et al., 2018; Müştak et al., 2012). However, 
CR E. coli was found with high rates in this study, 
and the occurrence of PMQR determinants was not 
always related with quinolone resistance. Yang et al. 
(2014) reported an increased prevalence of PMQR 
traits from 6.2–28.1% in 2004/2005 to 23.2–50.4% in 
2010/2011, while ciprofloxacin resistance was rela-
tively stable during the study period in China. 
Several studies have shown the prevalence of 
PMQR genes in E. coli isolates from chicken meat 
products (Ghodousi et al., 2015; Literak et al., 2013; 
Yu et al., 2015). In this study, none of the PMQR 
genes (qnrA, qnrB, qnrS, qnrC, qnrD, and aac(6’)-
Ib-cr) were determined to be present in the 59 E. coli 
isolates. The prevalence of the PMQR genes (qnrA) 
in Italy was determined as 91% in nearly all of the E. 
coli isolates from the chicken meat samples (Ghodou-
si et al., 2015). On the other hand, PMQR genes were 
reported as 4% and 7.8% in the Czech Republic and 
China, respectively (Literak et al., 2013; Yu et al., 
2015). Additionally, in other studies carried out in 
Turkey, a low-level presence of the PMQR gene was 
reported (Kürekci et al., 2018; Müştak et al., 2012). 
Previously in Turkey, Müştak et al. (2012) reported 
the presence of only the qnrA of the PMQR gene in 
five (5.3%) samples of 94 isolated chicken E. coli 
cloacal swaps. More recently, qnrS (n = 5) and qnrB 
(n = 8) of the PMQR genes from chicken meat were 
reported among the ESBL-producing E. coli strains 
obtained from chicken meat samples; however, qnrA, 
qnrC, qnrD, and aac(6’)-Ib-cr genes were not found 
(Kürekci et al., 2018). 
Quinolones are known to occur mainly through the 
accumulation of target enzyme point mutations. DNA 
gyrases (gyrA and gyrB) tend to be the primary target 
of quinolone in gram-negative bacteria, including E. 
coli, whereas in gram-positive bacteria, topoisomer-
ase IV (parC and parE) is the primary target (Vanni et 
al., 2014). However, in the current study, E. coli iso-
lates were not examined for chromosomal mutations. 
In addition, only PMQR genes were investigated in E. 
coli isolates, and PMQR genes were found in none of 
the isolates. In a study conducted by Xu et al. (2014), 
four topoisomerase point mutations showed ciproflox-
acin MIC ≥ 32 µg/mL in all E. coli isolates, and the 
authors noted that higher ciprofloxacin MIC usually 
had more complex quinolone-resistant determinants, 
including PMQR mechanisms. In the same study (Xu 
et al., 2014), PMQR determinants were identified in 
more than 60% of the E. coli isolates. Xu et al. (2014) 
also noted the MIC value of ciprofloxacin was highly 
related to the accumulation of a resistance mechanism. 
A meaningful correlation has been reported be-
tween ESBL (together with CTX-M types) and PMQR 
genes (Branger et al., 2005; Nordmann and Poirel, 
2005). In a recent study of ESBL E. coli in milk and 
chicken meat samples by Kürekci et al. (2018), a sig-
nificantly high rate of ESBL (86.7%) E. coli strains 
were reported to be isolated, and the authors noted 
that the CTX-M gene was quite prevalent (62.3%) 
in these isolates. In this study, 8.3% of the isolated 
CR E. coli was determined to be ESBL-positive, and 
two isolates (3.4%) possessed the blaCTX-M and blaC-
MY-2 genes, whereas 40 isolates (67.8%) possessed the 
blaTEM gene. Similar findings were reported from oth-
er studies (Cohen Stuart et al., 2012; Xu et al., 2014; 
Yu et al., 2015). Moreover, all ampicillin-resistant 
isolates were positive for the presence of the blaTEM 
gene. Literak et al. (2013) reported similar results for 
broiler samples in the Czech Republic. 
CONCLUSION 
The current study showed high rates of CR E. coli 
among retail chicken meat samples. Therefore, the 
prudent use of antimicrobial agents is an important 
issue to poultry farmers in Turkey. Although MDR 
was found to be high, the absence of the PMQR gene 
was favorable in terms of a public health concern. 
Hence, continuously investigating the MDR level and 
the feasibility of the limitations of antibiotics and the 
restrictions is essential. 
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